Full Data on Two Heart Drugs Find No Better Results Than Placebos, New York Times Reports
Full data on two heart drugs, revealed Saturday, showed the drugs were no better than placebos by every measure, The New York Times reported.
The New York Times reported that full data on two heart drugs, revealed on Saturday, showed that by every measure the drugs were "no better than placebos." The report was written by Gina Kolata and published on November 7, 2026, according to its byline and timestamp. Read the New York Times report on the full data.
The outlet's headline describes how cardiologists came to have high hopes for the two drugs, and the article's framing centers on the gap between those hopes and the results. The summary does not describe the cardiologists' expectations in detail, nor does it say what those expectations were based on.
The New York Times summary poses a question that the report appears to take up: was the outcome the fault of the design of the studies, or of the hypotheses about heart disease that the drugs tested? The summary does not answer that question and does not say which explanation the full article supports.
The summary does not name the two drugs or the companies that make them, and it does not give the number of people in the studies, their length, or their design. Those details, if the full article contains them, were not part of the material available for this report.
The headline and summary from The New York Times are the sole basis for the facts reported here. No statements from the drug makers, the researchers, or other experts are included in the material available for this report, and this report does not assess the research or the explanations offered for the results.
Sources: The New York Times: How Cardiologists’ High Hopes for Two Drugs Were Dashed.